Mackenzie Financial Corp Vanda Pharmaceuticals Inc. Transaction History
Mackenzie Financial Corp
- $63.2 Billion
- Q2 2024
A detailed history of Mackenzie Financial Corp transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 10,937 shares of VNDA stock, worth $51,841. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,937
Previous 14,964
26.91%
Holding current value
$51,841
Previous $61,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VNDA
# of Institutions
156Shares Held
45.1MCall Options Held
136KPut Options Held
220K-
Black Rock Inc. New York, NY8.14MShares$38.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.11MShares$19.5 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$16.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.15MShares$10.2 Million1.49% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.01MShares$9.55 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $268M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...